Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.71 |
| ▸ | KCNA5 | P22460 | 9/20 | 0.70 |
| ▸ | SCN5A | Q14524 | 9/20 | 0.70 |
| ▸ | KCND2 | Q9NZV8 | 5/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | YWHAG | P61981 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13461775 | 1.00 | SLC6A4 (0.71) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL411158 | 0.91 | SLC6A4 (0.72) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL14849214 | 0.91 | SLC6A4 (0.72) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL409729 | 0.90 | SLC6A4 (0.70) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL14851637 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL410599 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL14390503 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL12122779 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL12296115 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL13097960 | 0.88 | SLC6A4 (0.84) | SLC6A4KCNA5SCN5AKCND2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150336887-A1 | SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS | CORREVIO CANADA CORP. (CA) | 2015-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336887-A1 | SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS | DDC, PAICS, CYP4F2 | SLC6A4 2113/4885KCNA5 3600/4885SCN5A 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.